Transmembrane Receptor Enzymes Flashcards

(35 cards)

1
Q

what aer the three types of transmembrane receptor enzymes

A

receptor tyrosine kinase
receptor serine/threonine kinase
receptor guanylyl cyclase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the types of receptor tyrosine kinases

A

insulin receptor
human epidermal growth factor receptor(HER)
platelet derived growth factor receptor(PDGF)
vascular endotheilai growth factor receptor (VEGF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the different types of receptor serine/threonin kinase

A

transforming growth factor B (TGF-B) receptor
activin and inhibin receptor
bone morphogenic protein(BMP) receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the type of reecptor guanylyl cyclase

A

atrial natriuretic peptide(ANP) receptor
GC-A
GCB
GCC receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the mechanism of receptor tyrosine kinase?

A

from inactive monomers, they become inactive dimers and cross phsophorylate and casue the active dimer
they can also become acitve dimers straight away, adn once they ligand bind, they result in the ligand bound active dimer, that result in the sigalling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which domain allow for auto phosphorylation of the tyrosine kinase receptors

A

Src homology 2 domain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how many ways can phosphorylation occure

A

auto phosphorylation and substrate phsophrylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the pathways that lead to cellular proliferation response ? from which receptor does it occure

A

EGFR Tyrosine kinase activation
- Mitogen activated protein Kinase Pathway
- Phospholipase Cy pathway
- Phosphatidylinositol 3 kinase athway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the Receptor Tyrosine Kinsae: PLCy pathway

A

When the PLCY is activaed by phosphorylation,
it converts PIP2 into DG and IP3

dag which is converted into PKC

IP3 causes CA2+ to increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe the receptor tyrosoine kinase:PI3K pathway

A

PI3 kInsae result in convertions of PIP2 into PIP3

PIP3 result in attraction of peckstrin homology with the phosphatidylinositol depdendeent kindase 1

Activation of Akt (Protein Kinase B )

promote cell survival and inhibit apoptosis by phosphorylating and inactivating pro-apoptotic proteins such as Bad and caspase-9.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe the MAPK signaling pathway

A

GDP to GTP at Ras

result on Raf creation
Mak
Map kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

list the epidermal growth factor receptor inhibitor that causes inhibition of cancer

A

HER1 inhibitors

drug name : Geftinib, erlotinib
biologics: cetuximab, panitumumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

list the epidermal growth factor receptor inhibitor that causes inhibition of breast cancer

A

HER2

small molecules: Lapatinib
biologics: Trastuzumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Platelt derived Growth Factor Receptor Inhibitor

A

Imatinib for cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vacsular Endothelial Growth Factor(VEGF) Receptor Inhibitor for Cancer

A

Sunitinib, Sorafenib
biologica: Bevacizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Vacsular Endothelial Growth Factor(VEGF) Receptor Inhibitor for Muscle Degeneration

A

Oligonucleotide drug: Pegaptanib binds and blocks VEGF actions via intravitreal injections

17
Q

what are some functions the Receptor Serin/Threonine kindase : Transforming Growth Factor B Receptor are related to?

A

Growth Arrest
Cancer
Promote Apoptosis
Fibrosis
Angiogenesis
Immunomodulation
Atherosclerosis
Inflammation

  • this thus makes it diffficult to design an inhibitor without causing any side effects
18
Q

receptors of Receptor Serine/ Theronin Kinase(TGFB) when the ligand binds

A

They will already be in a dimer and once the receptor binds, they become heterotetramer(dimer bind with dimer)
cross phosphorylation would happen adn then the MH2 AND MH1 Rsmad would be attracted

19
Q

what is SMAD

A

It has a mad homology1 and mad homology 2
- mad holomolgy 1 bind ot DNA while mad homology 2 bings for receptor kinase interactions and causes trasncriptional activation

20
Q

For bone morphology protein what are the R smads

21
Q

for TGF-B what are the R smad

22
Q

what are cosmads

A

they are smad4 that combine with Rsmad to move into the nucleus and regulate gene expression

23
Q

inhibitory smad

A

6, 7
interact with Rsmad and ensure they cannot bind tot eh DNA, thus no gene trasncription process

24
Q

Drug development for TGF B receptor signaling- Anti-TFG-B mAb

25
Drug development for TGF B receptor signaling- TBRI Kinase inhibitor
Vactosertib
26
Drug development for TGF B receptor signaling- Recombinant Human Bone Morphogenic Protein
rhBMP-2- for spinal deformity rhBMP-7- for bone nonuniors
27
Drug development for TGF B receptor signaling- Activin Receptor Ligand Traps
Activin Receptor Type IIB-Fc Fusion Protein Luspatercept- Anemia in B thalassemia
28
Drug development for TGF B receptor signaling- Activit Receptoy type IIA-Fc Fusion protien
Sotatercept- Pulmanory Arterial hypertension(PAH)
29
What happens when TGF-B binds to the TBRII and TBRI recpetors
smad2or 3 will be released after the cross phosphorylation of the heterotetramer the smad2/3 binds with the COSMAD to modulate the geen expression
30
Receptor Guanylyl Cyclase(GC) what are they and their ligands
there are NPR-A (GCA)- Atrial NP(ANP) and Brain NP(BNP) NPR-B CNP from endothelial and renal cells NPR-C clearance receptor for anp, bnp, cnp GCC- Uroguanylin and Guanylin GCA, GCB, GCC- are mainly in the CVS, skeletal system adn GI tract GCD AND GCG- absent in the human GCE AND GCF- in the retinal photoreceptors
31
how many domains do the Natruretic peptide receptor have
ligand binding domin kinse homology domain hinge region Guanylyl cyclase domain
32
drugs for the Natriuretic Peptide Receptors
ANP: Carperitide, for short term acute decompensated CHF BNP: Mesiritide: for short terms acute decompensated CHF CNP: cenderititde for natiuresis, diuresis and cardiac fibrosis
33
function of PCGA
Natrurietic aterial vasodialtion renin and aldosterone suppressing anti apoptotic anti hypertrohic lusitropic lipolytic
34
function of PGCB
anti fibrotic anti inflammatory vascular regenerating
35
GCC receptor agonist
linaclotid and plecanatide for chronic idiopathic constipation and IBD predominant constipation and GI tumorigenesis